# Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women

> **NCT03043326** · — · UNKNOWN · sponsor: **Asociación Civil Impacta Salud y Educación, Peru** · enrollment: 1000 (estimated)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** Tenofovir Disoproxil Fumarate and Emtricitabine

## Key facts

- **NCT ID:** NCT03043326
- **Lead sponsor:** Asociación Civil Impacta Salud y Educación, Peru
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01-23
- **Primary completion:** 2020-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043326, "Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03043326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*